This section of the website is for patients who have been prescribed IQIRVO® (elafibranor) in the UK. Information for members of the general public can be found here.
This medicinal product has a conditional marketing authorisation.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

PBC & Me: Managing Side Effects

Primary Biliary Cholangitis (PBC) Video
09:55

This video prepares you for what to expect while taking elafibranor and how to manage any side effects.

You’ll find out:
• What side effects can occur and how common they are
• What typical side effects may feel like and how long they might last
• Simple ways side effects may be managed in everyday life
• When it’s important to contact your healthcare team

It also helps you feel reassured by explaining that many side effects are mild and temporary and highlights the importance of speaking to your healthcare team so you can stay on treatment safely.

ELA-UK-000419 | July 2026

Explore more Primary Biliary Cholangitis (PBC) Patient Support

Explore more Primary Biliary Cholangitis (PBC) Patient Support

Browse

To access relevant information about Primary Biliary Cholangitis, please confirm the following:

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.